iQemo electronic chemotherapy prescribing system can now be purchased via the G-Cloud 11 framework.
iQ HealthTech are pleased to announce that their iQemo electronic chemotherapy prescribing system can now be purchased via the G-Cloud 11 framework. Being available on the G-Cloud framework demonstrates the quality of the iQemo product and acts as a confirmation of our strict standards on data security.
The G-Cloud framework is a series of agreements between the UK government and suppliers who provide cloud-based services. The G-Cloud framework is managed by the Crown Commercial Services and provides a simple way for UK public sector bodies to choose and buy cloud computing services. The G-Cloud framework supports the governments ‘Cloud First Policy’ to access and use cloud-based services in a flexible and agile fashion, buying only the services needed, when they are needed.
One of the advantages of the iQemo system is that it is a cloud hosted Software as a Service application, this means that an NHS Trust can purchase the system as an off the shelf service without the need to install any software or manage any server hardware. This significantly reduces the cost of ownership in comparison to an on-premise hosted solution. iQ HealthTech provide a complete implementation support package priced according to the size of the chemotherapy service being run by an NHS hospital.
Purchasing iQemo through the G-Cloud framework further benefits an NHS Trust by enabling a more cost-effective buying process. With the G-Cloud framework Trusts do not have to open an OJEU invitation to tender (ITT), request for price (RFP), request for quote (RFQ), request for information (RFI) or negotiation. All service and pricing information is available directly from the G-Cloud 11 framework website.
iQ HealthTech was established in 2011 by a founding-team of software developers and a practicing consultant oncologist. With a team of subject experts working across design, development, implentations and customer success, the company develops people-centric technology with the goal of improving patient outcomes, everywhere. The company delivers innovative Saas and standalone platforms, including iQemo – the industry-leading, end-to-end chemotherapy prescribing and management platform used by NHS and private hospitals in the UK, and a growing number of hospitals worldwide. Learn more
Sign up to our newsletter and stay updated with industry-leading advice, insight and more…
iQemo, from iQHealthTech, provides specialist chemotherapy prescribing. A complete end-to-end solution that includes predefined regimens, prescribing, scheduling and dispensing, through to chemotherapy administration and reporting. iQemo is used in NHS Trusts and private hospitals in the UK, and in a growing number of hospitals worldwide. Learn More
iQ HealthTech was established in 2011 by a founding-team of software developers and a practicing consultant oncologist. With a team of subject experts working across design, development, implentations and customer success, the company develops people-centric technology with the goal of improving patient outcomes, everywhere. Learn more
We'd love to discuss how iQemo could support your organisation, people and patients.
Get in touch